FRANKLIN LAKES, NJ, November 24, 2021 / PRNewswire / – BD (Becton, Dickinson and Company) (NYSE: BDX), one of the world’s leading medical technology companies, announced today Francesca De Martino has been appointed senior vice president of investor relations for the company, effective 29 november.
In this role, DeMartino will lead all aspects of communicating the progress of the BD2025 strategy to investors and the financial community, including company initiatives that generate shareholder value. DeMartino will report to Chris DelOrefice, Executive Vice President and Chief Financial Officer of BD. she succeeds Kristen stewart who was named senior vice president of corporate strategy and ideas for BD.
âFrancesca is an accomplished leader with a long history of successful investor relations, including extensive experience in the medical technology industry,â said DelOrefice. “She will lead BD’s efforts to highlight key milestones in implementing our strategy to drive growth through innovation.”
DeMartino has over 20 years of combined experience in investor relations, communications and corporate finance, with his most recent role as Vice President of Investor Relations at Medtronic. During his tenure, the function received RI Magazine award for the best overall investor relations and the best investor relations in health care. She previously served as Vice President of Corporate Communications and Vice President of Global Communications for the Diabetes Group. Prior to joining Medtronic, DeMartino held positions of increasing responsibility at Johnson & Johnson, OMRIX Biopharmaceuticals, Macrocure Ltd, GCI Group and The Ruth Group. She started her career at Deutsche Bank AG as a financial analyst within the Health Care Investment Banking group.
DeMartino holds a Bachelor of Arts in International and Regional Studies from the University of California, Berkeley and a minor in business administration from the Walter A. Haas School of Business.
BD is one of the world’s largest medical technology companies, advancing the healthcare world by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the front lines of healthcare by developing innovative technologies, services and solutions that help advance both clinical therapy for patients and the clinical process for healthcare providers. BD and its 70,000 employees have the passion and commitment to help improve the safety and efficiency of the clinician care process, enable laboratory scientists to accurately detect disease and advance patient care. capacities of researchers to develop the next generation of diagnostics and therapies. BD has a presence in virtually every country and partners with organizations around the world to solve some of the world’s toughest health problems. By working closely with its customers, BD can help improve results, reduce costs, increase efficiency, improve safety and expand access to healthcare. For more information on BD, please visit bd.com or contact us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.
View original content to download multimedia: https://www.prnewswire.com/news-releases/bd-names-francesca-demartino-as-senior-vice-president-of-investor-relations-301431199.html
SOURCE BD (Becton, Dickinson and company)